Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

Specimen Handling 4Docetaxel 3pertuzumab 2Trastuzumab 2Taxes 2Paclitaxel 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2trastuzumab biosimilar HLX02 1pembrolizumab 1fisetin 1Surgical Procedures, Operative 1Simvastatin 1PF-05280014 1Ontruzant 1Ogivri 1Minoxidil 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Educational Status 1Early Intervention, Educational 1Doxorubicin 1Disulfides 1Biopsy 1Behavior Therapy 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anatomic Stage I Breast Cancer AJCC v8 × Aromatase Inhibitors × Clear all
NCT06534125 2026-01-29

Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer

Emory University

Phase NA Recruiting
150 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡